Announcement of allotment results
Filed with HKEX · · 16 pages · English
Summary by 6ix AI
This filing is an announcement of allotment results for Shaanxi Micot Pharmaceutical Technology Co., Ltd., detailing the outcome of its global offering. The announcement includes information on the number of shares offered, the final offer price, and the allocation results for both the Hong Kong public offering and the international offering. It highlights the high subscription levels and the concentration of shareholding among a small number of shareholders, which may affect share price volatility. The document also confirms compliance with listing rules and provides additional information regarding the allocation of shares to cornerstone investors.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Shaanxi Micot Pharmaceutical Technology Co., Ltd. on 6ix
Earlier from Shaanxi Micot Pharmaceutical Technology
Later from Shaanxi Micot Pharmaceutical Technology
- 2026 Interim report
- Notification letter to non-registered shareholders and reply form
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Proposed adoption of the h share incentive scheme and proposed general mandate to repurchase h shares
- Proposed general mandate to repurchase h shares and notice of extraordinary general meeting
Follow Shaanxi Micot Pharmaceutical Technology into a list and get an email when it puts out news.
Follow Shaanxi Micot Pharmaceutical Technology